Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 2/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | KLK7 | P49862 | 1/20 | 0.30 |
| ▸ | KLK14 | Q9P0G3 | 1/20 | 0.30 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14698532 | 1.00 | METAP2 (0.32) | METAP2CNR1KLK7KLK14KLK5 | |
| SCHEMBL14698109 | 0.86 | METAP2 (0.36) | METAP2CNR1KLK7KLK14KLK5 | |
| SCHEMBL14698538 | 0.81 | C1R (0.33) | KLK7KLK14KLK5 | |
| SCHEMBL14698537 | 0.81 | C1R (0.33) | KLK7KLK14KLK5 | |
| SCHEMBL14698293 | 0.71 | MALT1 (0.34) | — | |
| SCHEMBL14698291 | 0.71 | MALT1 (0.34) | — | |
| SCHEMBL16014835 | 0.70 | — | — | |
| SCHEMBL17417209 | 0.70 | — | — | |
| SCHEMBL14698498 | 0.68 | TRPM5 (0.35) | — | |
| SCHEMBL14698499 | 0.68 | TRPM5 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-19 | — | — | US | disclosed |
| EP-2742038-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2014-06-18 | — | — | EP | disclosed |
| WO-2013024006-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | BASF SE (DE) | 2013-02-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140171316-A1 | ANTHRANILAMIDE COMPOUNDS AND THEIR USE AS PESTICIDES | ANTXR2, NQO2, AAAS | METAP2 975/4885CNR1 2035/4885KLK7 3448/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.